SCHEMBL4841777

SCHEMBL4841777

CC(C)(C)[Si](OCc1cccc(C#CCCCCO)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.43
HTR2B P41595 2/20 0.43
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
EGFR P00533 1/20 0.35
ALK Q9UM73 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
BACE1 P56817 1/20 0.34
FFAR1 O14842 1/20 0.33
CYP2D6 P10635 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848468 0.79 CYP4F2 (0.41)
SCHEMBL5555724 0.78 ALDH1A1 (0.35) EGFRALKKDM4EALDH1A1
SCHEMBL8024035 0.76 CYP4F2 (0.46)
SCHEMBL12989590 0.76 CYP3A4 (0.36) HTR2CHTR2BKDM4EALDH1A1CYP1A2
SCHEMBL12988363 0.76 CYP3A4 (0.36) HTR2CHTR2BKDM4EALDH1A1CYP1A2
SCHEMBL10422902 0.76 HTR2C (0.38) HTR2CHTR2BCHRNB4CHRNA3EGFR
SCHEMBL8024443 0.76 MRGPRX4 (0.38) EGFRMAPT
SCHEMBL12989787 0.75 CYP3A4 (0.35) HTR2CHTR2BKDM4EALDH1A1CYP1A2
SCHEMBL15644046 0.75 CYP3A4 (0.35) HTR2CHTR2BKDM4EALDH1A1CYP1A2
SCHEMBL15643694 0.75 CYP3A4 (0.35) HTR2CHTR2BKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE40558-E1 Therapeutic uses of di-aryl acid derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-10-28 US disclosed
US-6635655-B1 Agonists or antagonists of peroxisome proliferator-activated receptors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-10-21 US disclosed
EP-1177187-A1 DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064888-A1 DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed